This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
£0.01939
Share price
0.00%
Change (1 day)
-99.28%
Change (1 year)
Categories
P/S ratio for ViewRay (VRAY)
P/S ratio on September 27, 2023 (TTM) : 0.0449
According to ViewRay's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0830. At the end of 2023 the company had a P/S ratio of 5.98.
P/S ratio history for ViewRay from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.98 | -24.82% |
| 2022 | 7.95 | -42.91% |
| 2021 | 13.9 | 39.99% |
| 2020 | 9.95 | 40.6% |
| 2019 | 7.08 | -2.03% |
| 2018 | 7.22 | -60.64% |
| 2017 | 18.3 | 199.86% |
| 2016 | 6.12 | -71.09% |
| 2015 | 21.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 0.0449 | 0.00% | 🇺🇸 USA |
 | 0.4365 | 873.07% | 🇺🇸 USA |
 | 26.9 | 59,921.09% | 🇮🇱 Israel |